The tweet was deleted by the author.
But we saved everything 🙂.
Nautilus Biotechnology is at the forefront of innovation in the proteomics space, driven by growing adoption in population studies and recognition of proteoforms' potential. The company’s evolving capabilities, such as Iterative Mapping, mark an exciting period for advancements in the field. Proteomics, which involves the large-scale study of proteins, continues to evolve, bringing promising new technologies and insights that can transform our understanding of biology and medicine.